1983, joined the management of Hangzhou Minsheng Pharmaceutical.
1995, as the chairman and president of the company.
In 2002, he was awarded the title of the 8th Zhejiang Management Master.
In 2003, he was awarded the title of "China Management Master" by the State Council Development Research Center.
In 2004, he was rated as a model worker in Zhejiang Province.
Zhu Fujiang's favorite books are Romance of the Three Kingdoms, The Water Margin and A Dream of Red Mansions.
He said that these three books condensed the three truths he advocated: wisdom, righteousness and affection.
Zhu Fujiang joined the management of Hangzhou Minsheng Pharmaceutical Group Co., Ltd. from 65438 to 0983 and served as the chairman and president of the company from 65438 to 0995. He led all employees of the company to seize opportunities and innovate. Today, the company's net assets exceed 500 million, ranking among the top 50 pharmaceutical companies in China, the first in chemical preparation manufacturing in Zhejiang, and the top ten pharmaceutical enterprises in Zhejiang. In 2002, Zhu Fujiang was named the chief entrepreneur of the US-China Economic Cooperation Organization and one of the top ten cross-century reformers in Zhejiang Province.
From 65438 to 0995, when Zhu Fujiang took office, he made two important decisions on enterprise marketing system and strategy: first, recruiting medical representatives nationwide and setting up sales offices in large and medium-sized cities; The second is to set up a drug sales branch directly under the group. In the enterprise management system, a new system of chief engineer, chief economist and several directors who assist the general manager has been established; Under the implementation of the branch division system, the subsidiary enterprises are managed in the form of wholly-owned, holding and shareholding, and the combination of capital management and product management is gradually realized. At the same time, the company's internal institutions, employment system, distribution system, personnel system and other reforms have also laid a solid foundation for the establishment of a modern enterprise system.
In view of China's accession to the WTO and the specific situation of intellectual property protection of patented products in various countries, Zhu Fujiang actively introduced talents, adjusted the new product development strategy and changed the product development mechanism. On the other hand, increase investment in science and technology. At present, more than 20 new varieties have been put into development. Up to now, more than 20 new drug certificates, approval numbers and clinical approvals have been obtained, and more than 20 are under application and preclinical research. Minsheng Group is now developing high-tech and high value-added products based on raw materials and focusing on preparations. At present, the pharmaceutical raw materials and preparations produced by the company all year round are divided into four categories, namely cardiovascular, anti-tumor, digestive tract and multi-dimensional elements.
After several years of efforts, the competitiveness and market share of the company's products have been greatly improved. At present, eight workshops (dosage forms) of Minsheng have obtained GMP certificates issued by the state and are in a leading position in the national pharmaceutical industry. The production workshop of raw material pharmaceutical factory passed the inspection of Hangzhou FDA for the first time after the software and hardware transformation, and the products can directly enter the American and European markets. Through the transformation of GMP and FDA, enterprises are in line with international standards in terms of plant facilities, production management and product quality, which greatly enhances their international competitiveness.
Through Zhu Fujiang's fruitful work, Minsheng Group has successfully implemented a high starting point, unconventional and leap-forward development strategy. Hangzhou Minsheng Pharmaceutical Co., Ltd. was identified as a scientific research and production base of high-efficiency chemical raw materials and various preparations by the relevant departments of Zhejiang Province and Hangzhou Municipal Government. At present, the group company now has 8 wholly-owned, holding and shareholding branches and enterprises with annual sales of 800 million yuan.